InBody Co.,Ltd (041830.KQ)
KRW 21950.0
(-1.13%)
KRW 21950.0
(-1.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 274.45 Billion KRW | 13.1% |
| 2022 | 242.66 Billion KRW | 19.09% |
| 2021 | 203.76 Billion KRW | 22.64% |
| 2020 | 166.15 Billion KRW | 7.26% |
| 2019 | 154.9 Billion KRW | 17.63% |
| 2018 | 131.68 Billion KRW | 17.55% |
| 2017 | 112.02 Billion KRW | 15.42% |
| 2016 | 97.05 Billion KRW | 17.71% |
| 2015 | 82.45 Billion KRW | 30.53% |
| 2014 | 63.17 Billion KRW | 17.7% |
| 2013 | 53.67 Billion KRW | 11.44% |
| 2012 | 48.16 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 296.85 Billion KRW | -0.46% |
| 2024 Q1 | 298.23 Billion KRW | 8.66% |
| 2023 Q4 | 274.45 Billion KRW | 1.01% |
| 2023 FY | 274.45 Billion KRW | 13.1% |
| 2023 Q1 | 255.7 Billion KRW | 5.37% |
| 2023 Q2 | 258.83 Billion KRW | 1.23% |
| 2023 Q3 | 271.71 Billion KRW | 4.98% |
| 2022 FY | 242.66 Billion KRW | 19.09% |
| 2022 Q4 | 242.66 Billion KRW | 2.13% |
| 2022 Q3 | 237.61 Billion KRW | 5.55% |
| 2022 Q2 | 225.12 Billion KRW | 3.66% |
| 2022 Q1 | 217.17 Billion KRW | 6.58% |
| 2021 Q1 | 179.24 Billion KRW | 7.88% |
| 2021 Q3 | 197.23 Billion KRW | 4.59% |
| 2021 Q4 | 203.76 Billion KRW | 3.31% |
| 2021 Q2 | 188.57 Billion KRW | 5.2% |
| 2021 FY | 203.76 Billion KRW | 22.64% |
| 2020 Q2 | 153.7 Billion KRW | -4.94% |
| 2020 FY | 166.15 Billion KRW | 7.26% |
| 2020 Q3 | 161.95 Billion KRW | 5.36% |
| 2020 Q1 | 161.69 Billion KRW | 4.38% |
| 2020 Q4 | 166.15 Billion KRW | 2.59% |
| 2019 Q4 | 154.9 Billion KRW | 0.94% |
| 2019 FY | 154.9 Billion KRW | 17.63% |
| 2019 Q3 | 153.45 Billion KRW | 4.76% |
| 2019 Q2 | 146.48 Billion KRW | 2.74% |
| 2019 Q1 | 142.58 Billion KRW | 8.27% |
| 2018 Q1 | 118.74 Billion KRW | 6.0% |
| 2018 Q4 | 131.68 Billion KRW | -2.24% |
| 2018 FY | 131.68 Billion KRW | 17.55% |
| 2018 Q2 | 138.21 Billion KRW | 16.4% |
| 2018 Q3 | 134.71 Billion KRW | -2.54% |
| 2017 FY | 112.02 Billion KRW | 15.42% |
| 2017 Q4 | 112.02 Billion KRW | 0.93% |
| 2017 Q3 | 110.98 Billion KRW | 8.35% |
| 2017 Q1 | 97.25 Billion KRW | 0.2% |
| 2017 Q2 | 102.43 Billion KRW | 5.32% |
| 2016 Q4 | 97.05 Billion KRW | 4.1% |
| 2016 FY | 97.05 Billion KRW | 17.71% |
| 2016 Q2 | 93.15 Billion KRW | 1.58% |
| 2016 Q1 | 91.7 Billion KRW | 11.22% |
| 2016 Q3 | 93.23 Billion KRW | 0.09% |
| 2015 Q3 | 79.25 Billion KRW | 7.94% |
| 2015 Q1 | 74.26 Billion KRW | 17.57% |
| 2015 FY | 82.45 Billion KRW | 30.53% |
| 2015 Q4 | 82.45 Billion KRW | 4.04% |
| 2015 Q2 | 73.42 Billion KRW | -1.13% |
| 2014 Q3 | 63.38 Billion KRW | 3.91% |
| 2014 Q4 | 63.17 Billion KRW | -0.34% |
| 2014 Q2 | 61 Billion KRW | 4.07% |
| 2014 Q1 | 58.61 Billion KRW | 9.21% |
| 2014 FY | 63.17 Billion KRW | 17.7% |
| 2013 Q2 | 52.43 Billion KRW | 2.74% |
| 2013 Q4 | 53.67 Billion KRW | -0.44% |
| 2013 FY | 53.67 Billion KRW | 11.44% |
| 2013 Q1 | 51.03 Billion KRW | 5.96% |
| 2013 Q3 | 53.9 Billion KRW | 2.81% |
| 2012 Q3 | 45.04 Billion KRW | 0.0% |
| 2012 FY | 48.16 Billion KRW | 0.0% |
| 2012 Q4 | 48.16 Billion KRW | 6.91% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Osang Healthcare Co.,Ltd | 320.54 Billion KRW | 14.379% |
| Curexo Inc. | 107.36 Billion KRW | -155.618% |
| Seegene, Inc. | 1251.45 Billion KRW | 78.069% |
| i-SENS, Inc. | 498.81 Billion KRW | 44.979% |
| Ray Co., Ltd. | 259.55 Billion KRW | -5.742% |
| Gencurix Inc. | 33.5 Billion KRW | -719.225% |
| Sugentech Inc. | 133.18 Billion KRW | -106.068% |
| L&C Bio Co., Ltd | 262.23 Billion KRW | -4.662% |